February 2017
Investor Review
This presentation contains forward-looking statements reflecting our current expectations that involve risks and uncertainties which are
subject to safe harbors under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as
amended, or the Exchange Act.
These forward-looking statements may include, but are not limited to, statements concerning our plans, objectives, expectations and
intentions, future financial position, future revenues, projected costs, expectations regarding demand and acceptance for our
technologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management.
The words “anticipates,” “believes,” “estimates," “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions
are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We
may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place
undue reliance on our forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in
the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in our Quarterly
Reports on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to
update any forward-looking statements.
2
Forward-Looking Statements
3
• Large market shifting towards Vocera
• Market leader with compelling ROI
• Large wins validate sales strategy
• Software acquisition extends platform
• Accelerating toward target financial model
*Earnings before interest, taxes, depreciation and amortization, and further excludes
stock -based compensation and change in fair value of warrant and option liabilities.
**Represents the high end of the company’s guidance range
Significant Value Creating Opportunity
(1) Joint Commission, an independent healthcare accreditation organization
(2) Agarwal et. al. Univ. of Maryland, 2010
92% of physicians use unsecured SMS text for
patient care, leading to data breeches and HIPAA
violations resulting in over $1.5M in fines per year
Efficient communication is a primary component
in driving patient engagement and satisfaction
Nurses often only spend 20% of their time
delivering direct care at the patient bedside
69% of accidental deaths and serious injuries in
hospitals are caused by communications breakdowns1
Cybercriminals
are increasingly going after targets in
the medical and healthcare verticals
$12 billion
wasted annually
In U.S. hospitals as a result of
communication inefficiencies2
4
Healthcare Communication Challenges
Market Forces Vocera Forces
5
Political Forces
Sales & Marketing
Product
Technology Forces
Device of Choice
CC&C
Unified Platform
ROI Selling
Cross Selling
System-level Deals
Meaningful Use Hangover
ACA Repeal
Medicare/Medicaid
Hospital Budgets
Scalability
Integration
Unified Platform
Strong Backlog/Def
Revenue
Approaching Target
model
2017 Context
Vocera Before Vocera Now
Communications
Badge-Centric
Point Product
Department Sale
Clinical Workflow
Software-Centric
Complete Solution
Enterprise Sale
Strategic Evolution
• Large System Deals
• Further penetrate existing
health system customers
• Continue pace of new
customer acquisition
Building momentum
across new products
• EHR Integration
• Collaboration Suite
• Clinical Integration
• Even Driven Alerts
• Care Experience
Extend Reach to
New Users
• Physicians
• Long Term Care
• Surgery Centers
Attractive International
Markets
• Canada
• United Kingdom
• Saudi Arabia
• UAE
• Qatar
• Australia
• Singapore
• Malaysia
Core Customer
Growth
Software
New Users
International
Expansion
7
Our Opportunity: Multiple Avenues for Growth
Quality ExperiencePatient-CenteredCost
Enhance how care is
provided to help
patients to achieve
better outcomes
Increase
Operational
Efficiencies
Improve patient
experience by allowing
caregivers to be
Patient Centered
Improve the caregiver
experience by improving
workflow and empowering
care teams
The Quadruple Aim
8
Our Mission
By enabling the care team to get the data, context, presence, and insights needed to…
Achieve the Quadruple Aim
Focus on the Patient Enhance workflows Make information
and help easier to find
9
How Do We Do That?
10
Communicate Engage
Experience
Improve response
times, patient care,
safety and satisfaction
Over 120 clinical
integrations
Secure Text,
Voice, Image
Clinical Communication and Collaboration
11
Hospital Staff Physicians Post Acute Home
Badge MC40-HC iPhone Android Tablets Desktop
Voice Secure Texting Clinical Integration
and Workflow
Patient Engagement
Vocera Software Platform
Communication and Clinical Workflows
Master Directory with Care Team Sync
Staff Assignment and On-Call Scheduling
Analytics and Reporting
Certified Security
Clinical System Integrations
Enterprise-Grade Communication Platform
The Vocera ApproachToday’s Situation
A Coordinated Approach
Alerts
Alarms
Messaging
Voice
Integrated with 120+ Clinical Systems
Quadruple Aim
Quality
Cost
Patient-
Centered
Experience
14
The Device of Choice Differentiator
Key Differentiators:
• Enterprise-class platform
(vs cobbling together vendors)
• Clinical Integration
• Device of Choice (Apple and Zebra)
• Vocera Badge resonates with nursing
• Superb References
• World-Class Support
and Professional Services
(1) Joint Commission, an independent healthcare accreditation organization
(2) Agarwal et. al. Univ. of Maryland, 2010 15
MEDCOM
Healthcare Recent Platform Wins Validate Strategy
16
Scalable, Secure and Integrated = we consistently win >70% of competitive sales
StatusQuo
• Pagers
• Overhead Paging
• Shouting or Walking
Wireless
Devices
• Spectralink
• Cisco
• Ascom
Smartphone
Apps
• Voalte
• Tiger Text
• Texting Solutions
• Mobile Apps
 Complete end-to-end solution
 Role-based intelligence
 Device of Choice
 Ease-of-use
 Hands-free
 Clinical integration
 Enterprise class
 Trusted provider
 Purpose-built device
 World class service and support
Competitive Landscape
6,986
Hospitals
in the U.S.(1)
U.S. Hospitals
1100+
(1)
Large Global Market Opportunity
(1 ) Based on Definitive US Healthcare Database
(2) Definitive Healthcare database
International
Healthcare Facilities
230+
Global Non-
Healthcare Facilities
270+
Fed Hospitals
Vocera Total
VA 68 153
DoD 32 64
Total 100 217
~$6 Billion Global Market Opportunity
5200 1108
18% U.S. Penetration Rate
(2)
(6308 Total US Hospitals)
17
18
10 minutes
per nurse per shift
Bed turnover
rates up 50%
OR revenues
up $780,000
350 more annual
OR capacity hours
4,000 annual ED
hours recaptured
Operational Efficiency
Response times down
from 2 minutes to
9 seconds
35% overall Sat Rating
improvement
25% improvement
in HCAHPS scores
Fall related injuries
down 60%; estimated
$1.27 mm savings
Patient Safety and Satisfaction
Compelling Return on Investment
19
• 60% revenues
are recurring
• High visibility
• Low customer
concentration
% of 2016
Revenue Revenue Streams
• Perpetual licenses
• Subscriptions
Software
*15%+ recurring
16%
• Software maintenance
• Technical support
Maintenance
*All recurring
34%
• Professional services
• Deployment & training
Services
*15%+ recurring11%
39% Devices
*50% recurring
• Badges
• Batteries, chargers, accessories
Diversified Revenue Streams
(1) Earnings before interest, taxes, depreciation and amortization, and further
excludes stock -based compensation and change in fair value of warrant and option liabilities.
Revenue Q4 2016 Highlights
Adjusted EBITDA
$28.4 $36.0
$104.1
$127.7
Q415 Q416 2015 2016
($inMillions)
$0.2 $1.3
-$2.8
$4.3
Q415 Q416 2015 2016
($inMillions)
Q4/2016 Results exceeded expectations
• Q4: 27% Revenue Growth, 2016: +23%
• Q4: 46% Software Growth, 2016: +35%
• 27% Backlog and Deferred Revenue Growth
Solid Customer Base and Value Proposition
• 95%+ s/w maintenance renewal rate
• Strong competitive win rate
Expanding Profitability and Cash Flow
• A-EBITDA $4.3 million in 2016
• $11.4 million operating cash flow in 2016
20
+27% +23%
Q4’16 Financial Highlights
21
2017 Revenue Visibility
$4.2
Rev from Def.
Rev/BL
Supplies Visible Revenue Book-ship 2017 Revenue
$161M
65-70%
22
Actual
2014 2015 2016
R&D % of Revenue 17% 15% 13%
S&M % of Revenue 47% 41% 37%
G&A % of Revenue 13% 12% 11%
~$200M
Target Model
12%
29%
8%
Sales
Notes
• All numbers are non-GAAP
• Mean peer group enterprise value comps are 3-4x Revenue and 12-15x A-EBITDA
Drivers
Operating Leverage Drives Significant Value
Thank you!

More Related Content

PDF
Vocerainvestordeck january-2017final-web
PDF
Medicenna corporate presentation march
PDF
Vocera february 2017 web
PDF
Commercial: PwC Top Issues
PDF
Medical Cost Trend: Behind the Numbers 2017
PDF
Mercer Capital's Value Focus: Medtech & Device Industry | Q4 2018
PDF
Current Accounting and Reporting Developments Webcast Series Q4
PDF
Investor relations Presentation - March 2016
Vocerainvestordeck january-2017final-web
Medicenna corporate presentation march
Vocera february 2017 web
Commercial: PwC Top Issues
Medical Cost Trend: Behind the Numbers 2017
Mercer Capital's Value Focus: Medtech & Device Industry | Q4 2018
Current Accounting and Reporting Developments Webcast Series Q4
Investor relations Presentation - March 2016

What's hot (20)

PDF
PwC Insurance -Stress-testing
PDF
1500090053
PDF
Healthcare’s Alternative Payment Landscape
PDF
Speaker 1
PDF
Marpai Investor Presentation November
PDF
PwC Managing Agent Change Report
PDF
December 2016 Investor Day Presentation
PDF
Cancer Genetics Earnings Call
PDF
1001205097
PPTX
The FDA and industry: A recipe for collaborating in the New Health Economy
PDF
Csod investor deck second quarter final
PDF
Hcd wp-2012-better analysisofrevenuecycleandvbp
PPTX
Provider Risk Readiness Report - Navigant/HFMA Survey
PDF
Asm17 0512
PDF
Overwhelming support: US public opinions on the manufacturing industy
PDF
Quintiles analyst day presentation 2014
PDF
4 Ways To Improve Revenue Cycle Management
PDF
AI in Healthcare Readiness Report 2019
PDF
RPA in Healthcare
PDF
Capital Allocation Strategies - Risk 2014, Dubai UAE
PwC Insurance -Stress-testing
1500090053
Healthcare’s Alternative Payment Landscape
Speaker 1
Marpai Investor Presentation November
PwC Managing Agent Change Report
December 2016 Investor Day Presentation
Cancer Genetics Earnings Call
1001205097
The FDA and industry: A recipe for collaborating in the New Health Economy
Csod investor deck second quarter final
Hcd wp-2012-better analysisofrevenuecycleandvbp
Provider Risk Readiness Report - Navigant/HFMA Survey
Asm17 0512
Overwhelming support: US public opinions on the manufacturing industy
Quintiles analyst day presentation 2014
4 Ways To Improve Revenue Cycle Management
AI in Healthcare Readiness Report 2019
RPA in Healthcare
Capital Allocation Strategies - Risk 2014, Dubai UAE

Viewers also liked (18)

PDF
Vocera Investor Deck Feb 2017
PDF
Vocera investordeck december web
PDF
Vocerainvestordeck january-2017final
PDF
Vocera investordeck february 2017
PDF
Vocera investordeck march 2017
PDF
Vmc investor presentation website march 2015
PDF
Vmc ir handout feb 2014
PDF
Principal Investor Day 2016
PDF
Vmc Investor Day Management Presentation 2015
PDF
Micron Investor Presentation
PDF
4Q 2016 Earnings Conference Call Presentation
PDF
Molson Coors Brewing Company 2016 NY Investor/Analyst Meeting
PDF
VMC investor handout
PDF
Principal Financial Group 101
PDF
The Principal Financial Group 101
PDF
Vmc aggregates day 2016.09.29 final
PPTX
FLICKR
PDF
Blood Cholesterol Managment.pptx
Vocera Investor Deck Feb 2017
Vocera investordeck december web
Vocerainvestordeck january-2017final
Vocera investordeck february 2017
Vocera investordeck march 2017
Vmc investor presentation website march 2015
Vmc ir handout feb 2014
Principal Investor Day 2016
Vmc Investor Day Management Presentation 2015
Micron Investor Presentation
4Q 2016 Earnings Conference Call Presentation
Molson Coors Brewing Company 2016 NY Investor/Analyst Meeting
VMC investor handout
Principal Financial Group 101
The Principal Financial Group 101
Vmc aggregates day 2016.09.29 final
FLICKR
Blood Cholesterol Managment.pptx

Similar to Vocera investordeck february 2017 web (1) (20)

PDF
Vocera investordeck may 12 2017 needham
PDF
Vocera investordeck web may 1 2017
PDF
Vocera investordeck web may 8 2017
PDF
Vocera investordeck june 2017 web
PDF
Vocera investordeck september 2017 for web
PDF
Vocera investordeck august 2017 web
PDF
Vocera investordeck july august 2017 web
PDF
Vocera ir march 2019 web
PDF
Vocera investordeck october 2017 for web
PDF
Investor Presentation
PDF
Vocera ir master_ february 2019 web
PDF
Vocera investordeck october 2018 web
PDF
Vocera investordeck november 2017 web
PDF
Vocera investordeck november 2017 web (1)
PDF
Vocera investordeck september 2018 web
PDF
Vocera investordeck -june-2018-web
PDF
Vocera jp morgan_1 2 19 2pm final
PDF
Vocera investordeck august 2018 web version
PDF
Vocera investordeck february 2018 web
PDF
Vocera investordeck november 2018 web
Vocera investordeck may 12 2017 needham
Vocera investordeck web may 1 2017
Vocera investordeck web may 8 2017
Vocera investordeck june 2017 web
Vocera investordeck september 2017 for web
Vocera investordeck august 2017 web
Vocera investordeck july august 2017 web
Vocera ir march 2019 web
Vocera investordeck october 2017 for web
Investor Presentation
Vocera ir master_ february 2019 web
Vocera investordeck october 2018 web
Vocera investordeck november 2017 web
Vocera investordeck november 2017 web (1)
Vocera investordeck september 2018 web
Vocera investordeck -june-2018-web
Vocera jp morgan_1 2 19 2pm final
Vocera investordeck august 2018 web version
Vocera investordeck february 2018 web
Vocera investordeck november 2018 web

More from vocera2016ir (13)

PDF
Vocera ir master_ may 2019 web-converted
PDF
Vocera ir master_ april 2019 web
PDF
Vocera investordeck december 2018 web
PPTX
Vocera investordeck may 25 web 2018
PDF
Vocera investordeck may 25 web 2018
PDF
Vocera investordeck may 15 2018 web
PDF
Vocera investordeck -may-15-2018web
PDF
Investor Presentation
PDF
Vocera investordeck may 2018 web
PDF
Investor Presentation - April 2018
PDF
Vocera investordeck march 2018 for web
PDF
Vocera investordeck web january 2018 (1)
PDF
Vocera investordeck web january 2018
Vocera ir master_ may 2019 web-converted
Vocera ir master_ april 2019 web
Vocera investordeck december 2018 web
Vocera investordeck may 25 web 2018
Vocera investordeck may 25 web 2018
Vocera investordeck may 15 2018 web
Vocera investordeck -may-15-2018web
Investor Presentation
Vocera investordeck may 2018 web
Investor Presentation - April 2018
Vocera investordeck march 2018 for web
Vocera investordeck web january 2018 (1)
Vocera investordeck web january 2018

Recently uploaded (18)

PDF
OR Royalties Inc. - Corporate Presentation, September 2025
PPTX
伦敦政治经济学院假毕业证LSE成绩单伦敦政治经济学院在读证明信学历认证
PPTX
Cost & Budgeting in the implementation perspective .pptx
PPTX
223Presentation2.pptxGUFYFDYVHGF6FVUF6UY
PDF
Mumbai c@ll girls# andheri c@ll girls# bandra Mumbai Nightlife Guide – Privat...
PPTX
胡安卡洛斯国王大学硕士毕业证URJC成绩单GPA修改URJC录取通知书学历认证
PDF
Collective Mining | Corporate Presentation - August 2025
PDF
(DONE)Module I_2_Structure and Function of Macromolecules.pdf
PPTX
sadfasfasdfasdfasdfadsffffffffffffffffffffffffffffffffffffffffffff
PPTX
Prezentacja HY 2025 EN prezentacjaaa.pptx
PDF
Methanex Investor Presentation - July 2025
PPT
presentations on market conduct and prudential regualtions ppt
PDF
Raheja CIRP Order 210825 - All Projects.pdf
PPTX
mutual funds services related presentation
PPTX
原版一样(SMC毕业证书)美国圣莫尼卡学院毕业证100%复刻研究生学历信息学历认证
PPTX
Comprehensive Portfolio Analysis and Management
PDF
Collective Mining | Corporate Presentation - September 2025
DOCX
MLS 112 Human Anatomy and Physiology with Pathophysiology (LECTURE).docx
OR Royalties Inc. - Corporate Presentation, September 2025
伦敦政治经济学院假毕业证LSE成绩单伦敦政治经济学院在读证明信学历认证
Cost & Budgeting in the implementation perspective .pptx
223Presentation2.pptxGUFYFDYVHGF6FVUF6UY
Mumbai c@ll girls# andheri c@ll girls# bandra Mumbai Nightlife Guide – Privat...
胡安卡洛斯国王大学硕士毕业证URJC成绩单GPA修改URJC录取通知书学历认证
Collective Mining | Corporate Presentation - August 2025
(DONE)Module I_2_Structure and Function of Macromolecules.pdf
sadfasfasdfasdfasdfadsffffffffffffffffffffffffffffffffffffffffffff
Prezentacja HY 2025 EN prezentacjaaa.pptx
Methanex Investor Presentation - July 2025
presentations on market conduct and prudential regualtions ppt
Raheja CIRP Order 210825 - All Projects.pdf
mutual funds services related presentation
原版一样(SMC毕业证书)美国圣莫尼卡学院毕业证100%复刻研究生学历信息学历认证
Comprehensive Portfolio Analysis and Management
Collective Mining | Corporate Presentation - September 2025
MLS 112 Human Anatomy and Physiology with Pathophysiology (LECTURE).docx

Vocera investordeck february 2017 web (1)

  • 2. This presentation contains forward-looking statements reflecting our current expectations that involve risks and uncertainties which are subject to safe harbors under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements may include, but are not limited to, statements concerning our plans, objectives, expectations and intentions, future financial position, future revenues, projected costs, expectations regarding demand and acceptance for our technologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates," “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in our Quarterly Reports on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to update any forward-looking statements. 2 Forward-Looking Statements
  • 3. 3 • Large market shifting towards Vocera • Market leader with compelling ROI • Large wins validate sales strategy • Software acquisition extends platform • Accelerating toward target financial model *Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities. **Represents the high end of the company’s guidance range Significant Value Creating Opportunity
  • 4. (1) Joint Commission, an independent healthcare accreditation organization (2) Agarwal et. al. Univ. of Maryland, 2010 92% of physicians use unsecured SMS text for patient care, leading to data breeches and HIPAA violations resulting in over $1.5M in fines per year Efficient communication is a primary component in driving patient engagement and satisfaction Nurses often only spend 20% of their time delivering direct care at the patient bedside 69% of accidental deaths and serious injuries in hospitals are caused by communications breakdowns1 Cybercriminals are increasingly going after targets in the medical and healthcare verticals $12 billion wasted annually In U.S. hospitals as a result of communication inefficiencies2 4 Healthcare Communication Challenges
  • 5. Market Forces Vocera Forces 5 Political Forces Sales & Marketing Product Technology Forces Device of Choice CC&C Unified Platform ROI Selling Cross Selling System-level Deals Meaningful Use Hangover ACA Repeal Medicare/Medicaid Hospital Budgets Scalability Integration Unified Platform Strong Backlog/Def Revenue Approaching Target model 2017 Context
  • 6. Vocera Before Vocera Now Communications Badge-Centric Point Product Department Sale Clinical Workflow Software-Centric Complete Solution Enterprise Sale Strategic Evolution
  • 7. • Large System Deals • Further penetrate existing health system customers • Continue pace of new customer acquisition Building momentum across new products • EHR Integration • Collaboration Suite • Clinical Integration • Even Driven Alerts • Care Experience Extend Reach to New Users • Physicians • Long Term Care • Surgery Centers Attractive International Markets • Canada • United Kingdom • Saudi Arabia • UAE • Qatar • Australia • Singapore • Malaysia Core Customer Growth Software New Users International Expansion 7 Our Opportunity: Multiple Avenues for Growth
  • 8. Quality ExperiencePatient-CenteredCost Enhance how care is provided to help patients to achieve better outcomes Increase Operational Efficiencies Improve patient experience by allowing caregivers to be Patient Centered Improve the caregiver experience by improving workflow and empowering care teams The Quadruple Aim 8 Our Mission
  • 9. By enabling the care team to get the data, context, presence, and insights needed to… Achieve the Quadruple Aim Focus on the Patient Enhance workflows Make information and help easier to find 9 How Do We Do That?
  • 10. 10 Communicate Engage Experience Improve response times, patient care, safety and satisfaction Over 120 clinical integrations Secure Text, Voice, Image Clinical Communication and Collaboration
  • 11. 11 Hospital Staff Physicians Post Acute Home Badge MC40-HC iPhone Android Tablets Desktop Voice Secure Texting Clinical Integration and Workflow Patient Engagement Vocera Software Platform Communication and Clinical Workflows Master Directory with Care Team Sync Staff Assignment and On-Call Scheduling Analytics and Reporting Certified Security Clinical System Integrations Enterprise-Grade Communication Platform
  • 12. The Vocera ApproachToday’s Situation A Coordinated Approach Alerts Alarms Messaging Voice
  • 13. Integrated with 120+ Clinical Systems Quadruple Aim Quality Cost Patient- Centered Experience
  • 14. 14 The Device of Choice Differentiator
  • 15. Key Differentiators: • Enterprise-class platform (vs cobbling together vendors) • Clinical Integration • Device of Choice (Apple and Zebra) • Vocera Badge resonates with nursing • Superb References • World-Class Support and Professional Services (1) Joint Commission, an independent healthcare accreditation organization (2) Agarwal et. al. Univ. of Maryland, 2010 15 MEDCOM Healthcare Recent Platform Wins Validate Strategy
  • 16. 16 Scalable, Secure and Integrated = we consistently win >70% of competitive sales StatusQuo • Pagers • Overhead Paging • Shouting or Walking Wireless Devices • Spectralink • Cisco • Ascom Smartphone Apps • Voalte • Tiger Text • Texting Solutions • Mobile Apps  Complete end-to-end solution  Role-based intelligence  Device of Choice  Ease-of-use  Hands-free  Clinical integration  Enterprise class  Trusted provider  Purpose-built device  World class service and support Competitive Landscape
  • 17. 6,986 Hospitals in the U.S.(1) U.S. Hospitals 1100+ (1) Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database (2) Definitive Healthcare database International Healthcare Facilities 230+ Global Non- Healthcare Facilities 270+ Fed Hospitals Vocera Total VA 68 153 DoD 32 64 Total 100 217 ~$6 Billion Global Market Opportunity 5200 1108 18% U.S. Penetration Rate (2) (6308 Total US Hospitals) 17
  • 18. 18 10 minutes per nurse per shift Bed turnover rates up 50% OR revenues up $780,000 350 more annual OR capacity hours 4,000 annual ED hours recaptured Operational Efficiency Response times down from 2 minutes to 9 seconds 35% overall Sat Rating improvement 25% improvement in HCAHPS scores Fall related injuries down 60%; estimated $1.27 mm savings Patient Safety and Satisfaction Compelling Return on Investment
  • 19. 19 • 60% revenues are recurring • High visibility • Low customer concentration % of 2016 Revenue Revenue Streams • Perpetual licenses • Subscriptions Software *15%+ recurring 16% • Software maintenance • Technical support Maintenance *All recurring 34% • Professional services • Deployment & training Services *15%+ recurring11% 39% Devices *50% recurring • Badges • Batteries, chargers, accessories Diversified Revenue Streams
  • 20. (1) Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities. Revenue Q4 2016 Highlights Adjusted EBITDA $28.4 $36.0 $104.1 $127.7 Q415 Q416 2015 2016 ($inMillions) $0.2 $1.3 -$2.8 $4.3 Q415 Q416 2015 2016 ($inMillions) Q4/2016 Results exceeded expectations • Q4: 27% Revenue Growth, 2016: +23% • Q4: 46% Software Growth, 2016: +35% • 27% Backlog and Deferred Revenue Growth Solid Customer Base and Value Proposition • 95%+ s/w maintenance renewal rate • Strong competitive win rate Expanding Profitability and Cash Flow • A-EBITDA $4.3 million in 2016 • $11.4 million operating cash flow in 2016 20 +27% +23% Q4’16 Financial Highlights
  • 21. 21 2017 Revenue Visibility $4.2 Rev from Def. Rev/BL Supplies Visible Revenue Book-ship 2017 Revenue $161M 65-70%
  • 22. 22 Actual 2014 2015 2016 R&D % of Revenue 17% 15% 13% S&M % of Revenue 47% 41% 37% G&A % of Revenue 13% 12% 11% ~$200M Target Model 12% 29% 8% Sales Notes • All numbers are non-GAAP • Mean peer group enterprise value comps are 3-4x Revenue and 12-15x A-EBITDA Drivers Operating Leverage Drives Significant Value